Relu® Reaches Medical Quality Standards with ISO13485 Certification

Relu, an OEM software provider in the dental industry, obtains ISO13485 certification from EU Notified Body Kiwa Dare. ISO13485 is the global quality standard for medical device companies.

Relu provides enterprise-grade AI for workflow automation in dental treatment software. They partner closely with leading dental software companies to make their software more valuable and user-friendly with AI. This ISO13485 certification will further increase the quality of Relu’s product, besides reducing the regulatory work of their partners when integrating AI in their medical device software. Relu takes this step to bring better AI innovation to both the dentist and the patient.

“This certification demonstrates our commitment to international quality and regulatory standards. Relu wants to build AI that people can trust.” says Holger Willems, Co-Founder & CEO at Relu.

“We’ve achieved ISO13485, underscoring our commitment to quality and safety. This certification reassures our global partners of our dedication to innovative AI solutions for implantology and orthodontics. It’s a clear mark of trust for all involved.” says Bindu Saran, Director at Relu and Former Global Head of Orthodontic Technology at Straumann Group.

SourceRelu

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”